BDNF and Alzheimer disease: Indeed, AD patients with mild to medium cognitive impairments commonly exhibit increased levels of proBDNF in cortex, hippocampus and cerebrospinal fluid (CSF) on the expense of reduced mature BDNF [40, 57–61].